Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: J Card Fail. 2012 Jul;18(7):534–540. doi: 10.1016/j.cardfail.2012.05.003

Table-1.

Comparison of baseline characteristics by Sleep Disordered Breathing group

Mean (SD) or n (%)

Patient Characteristic CSA (n=165) OSA (n=480) No SDB (n=139)

Age 60.3 (15.0)* 59.5 (13.4) 54.2 (15.9)

Sex (male) 137 (83%)* 347 (72%) 70 (50%)

Cardiomyopathy
Ischemic 106 (64%) 312 (65%) 75 (54%)
Dilated 35 (21%)* 121 (25%) 47 (34%)
Others 24 (15%) 47 (10%) 17 (12%)

LVEF 22.2 (9.4) * 25.4 (10.7) 29.2 (10.3)

BMI kg/cm2 28.4 (6.2) 31.2 (7.8) 29.8 (10.4)

Length of Stay 9.6 (10.7) 8.8 (10.9) 8.6 (9.7)

Creatinine (mg/dL) 1.39 (0.75) 1.38 (0.82) 1.32 (0.74)

Coronary artery disease 107 (65%) 341 (71%) 79 (57%)

Diabetes 57 (35%) 227 (47%) 41 (30%)

Discharged on ACEI or ARB 133 (81%) 407 (85%) 106 (76%)

Discharged on beta-blockers 150 (91%) 436 (91%) 118 (85%)

Discharge SBP < 110 mmHg 51 (31%) 135 (28%) 46 (33%)

Admission Na 136.8 (4.2) 136.5 (3.7) 136.6 (3.5)

Admission Hemoglobin 12.2 (1.8) 12.1 (2.0) 12.1 (2.0)
*

P<0.05 for the comparison between CSA and the NO SDB group

P<0.05 for the comparison between OSA and the NO SDB group

P<0.05 for the comparison between CSA and OSA groups

BMI; body mass index; SDB: sleep disordered breathing; CSA: central sleep apnea; OSA: obstructive sleep apnea. LVEF: Left ventricular ejection fraction; ARB: angiotensin receptor blocker; ACEI: angiotensin-converting enzyme inhibitor, SBP: systolic blood pressure.